Evidence map›Paper›PMID 34817696›Full record

ReviewWorld journal of microbiology & biotechnology2021

Application of bacterial tyrosinases in organic synthesis.

Mayowa Agunbiade, Marilize Le Roes-Hill

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of microbiology & biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mayowa AgunbiadeApplied Microbial and Health Biotechnology Institute, Cape Peninsula University of Technology, PO Box 1906, 7535, Bellville, South Africa.ORCID http://orcid.org/0000-0002-2494-6779
Marilize Le Roes-HillApplied Microbial and Health Biotechnology Institute, Cape Peninsula University of Technology, PO Box 1906, 7535, Bellville, South Africa. LeroesM@cput.ac.za.ORCID http://orcid.org/0000-0002-1930-2637
Cape Peninsula University of Technology · ZA

Funding

National Research Foundation of South Africa 105873
6 · The paper itself

Abstract

Bacterial tyrosinases, as in the case of other bacterial oxidative enzymes, have been found to possess biochemical characteristics that typically make them more suited to applications requiring special operational conditions such as alkaline pH, high or low temperature, the presence of organic solvents, and the presence of inhibitors. Even though a great deal is known about fungal tyrosinases, bacterial tyrosinases still vastly remain underexplored for their potential application in organic synthesis. A literature survey in particular highlights the gaps in our knowledge pertaining to their biochemical properties. Bacterial tyrosinases have not only shown promise in the synthesis of medically important compounds such as L-3,4-dihydroxyphenylalanine (L-DOPA) and melanin but have also seen application in cross-linking reactions of proteins and the polymerization of environmental pollutants. Their ability to catalyse o-hydroxylation reactions have shown some degree of promise in the biocatalytic conversion of resveratrol to piceatannol, tyrosol to hydroxytyrosol, and many more. In this review, we will explore the world of bacterial tyrosinases, their current applications, and future perspectives for the application of these enzymes in organic synthesis.

Indexed as

BacteriaBacterial ProteinsBiocatalysisChemistry Techniques, SyntheticHydroxylationMonophenol MonooxygenaseBacterial ProteinsMonophenol MonooxygenaseBacteriaCross-linkingL-DOPAMelaninOrganic synthesisTyrosinase

Identifiers

PMID34817696
OpenAlexW3215690869

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.